Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Shanghai City, China Clinical Trials

A listing of Shanghai City, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (68) clinical trials

A Rollover Study to Provide Continued Treatment With Eltrombopag

This study will provide continued access to treatment with eltrombopag for subjects who are currently participating in a GlaxoSmithKline (GSK) sponsored investigational study of eltrombopag (parent study) and to collect long term safety data.

Phase

1.15 miles

Learn More »

Combined Retinoic Acid Arsenic Trioxide and Chemo for Newly-diagnosed APL

In this prospective randomized study for patients with newly diagnosed acute promyelocytic leukemia. For induction, all patients will be randomized into two groups which received treatment composed of retinoic acid combined with arsenic trioxide versus retinoic acid combined with chemotherapy. For consolidation, the experimental group recieved 2 cycles of ATRA+arsenic ...

Phase

1.15 miles

Learn More »

The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa

The main objective of the study is to explore firstly, then further evaluate and confirm the efficacy between Pramipexole Sustained Release (SR) versus Pramipexole Immediate Release (IR) on nocturnal symptoms (as measured by the change from baseline to the end of the maintenance period in Parkinson's Disease Sleep Scale 2nd ...

Phase

1.15 miles

Learn More »

ACEI/CCB Versus ACEI/DIU Combination Antihypertensive Therapy in Chinese Hypertensive Patients (ACvAD)

Study name: ACEI/CCB versus ACEI/DIU combination antihypertensive therapy in Chinese hypertensive patients (ACvAD) Medicine: Benazepril 10 mg / amlodipine besylate 5 mg fixed-dose combination, benazepril 10 mg / hydrochlorothiazide 12.5 mg fixed-dose combination. Rationale: A meta-analysis of 42 studies showed that the combination of two antihypertensive drugs is better than ...

Phase

1.15 miles

Learn More »

Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Subjects With Chronic Kidney Disease

Approximately 102 ESA-nave subjects and 204 ESA-treated subjects will be enrolled and randomized respectively in a 1:1 ratio to receive roxadustat at one of two starting doses as below Low weight-based dosing: 70 mg TIW for body weight < 60 kg or 100 mg TIW for body weight 60 kg ...

Phase

1.15 miles

Learn More »

Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer

The purpose of this single arm study is to assess the safety and efficacy of ATAN (Apatinib) in patients with Chemo-refractory Advanced or Metastatic Adenocarcinoma of Stomach or Gastroesophageal Junction in clinical practice. ATAN will be given to patients who had failed at least two lines of prior chemotherapy. Eligible ...

Phase

1.2 miles

Learn More »

Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients

Patients who have completed 2-years entecavir-based treatment in Regress Study will receive another 5-years entecavir extension therapy. Patients will be assessed at baseline and every six months for blood cell count, liver function test, HBVDNA, AFP, prothrombin time, liver ultrasonography, and Fibroscan; A third liver biopsy will be performed at ...

Phase

1.66 miles

Learn More »

Efficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced Patients

To investigate whether sequential combination therapy with Thymosin alpha 1 and entecavir is superior to continuous ETV monotherapy in HBeAg-positive chronic hepatitis B patients with previous long-term entecavir therapy ( 1 years), and to select the optimal patients who may benefit from sequential combination therapy.

Phase

1.66 miles

Learn More »

Protective Effects of Saxagliptin (And Vitamin D3) on Cell Function in Adult-onset Latent Autoimmune Diabetes

LADA is actually a form of type 1 diabetes, which is caused by autoimmune damage of islet cells and triggered by environmental factors based on genetic susceptibility. LADA shows some characteristics of type 2 diabetes at its onset, which develops slowly and latent, and easily be misdiagnosed as type 2 ...

Phase

1.81 miles

Learn More »